« Back to Record
Citation APA

Gebhart, G., Gamez, C., Holmes, E., Robles Barba, J., Garcia, C., Cortés, M., de Azambuja, E., Fauria, K., van Dooren, V., Aktan, G., Coccia-Portugal, M., Kim, S.-B., Vuylsteke, P., Cure, H., Eidtmann, H., Baselga, J., Piccart-Gebhart, M., Flamen, P., & Di Cosimo, S. (2013). 18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO. The Journal of nuclear medicine, 54(11), 1862-1868. doi:10.2967/jnumed.112.119271


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/199121

Gebhart, G., Gamez, C., Holmes, E., Robles Barba, J., Garcia, C., Cortés, M., de Azambuja, E., Fauria, K., van Dooren, V., Aktan, G., Coccia-Portugal, M., Kim, S.-B., Vuylsteke, P., Cure, H., Eidtmann, H., Baselga, J., Piccart-Gebhart, M., Flamen, P., & Di Cosimo, S. (2013). 18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO. The Journal of nuclear medicine, 54(11), 1862-1868. doi:10.2967/jnumed.112.119271